Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Waterloo

$23,000.00

Molecular and bioprocessing strategies in posttranslational processing to enhance recombinant protein production

EF 2013-14

Résumé
In this proposed research, various molecular and bioprocessing aspects associated with disulfide bond formation will be explored and integrated with the strategies for gene overexpression to improve the performance of heterologous expression. Two eukaryotic proteins, i.e. an industrial enzyme of PalB and a therapeutic protein of hCD83ext, will be used as the model molecules for study. PalB contains three intramolecular disulfide bonds which are critical for its solubility and enzymatic activity, whereas hCD83ext contains five cysteine residues involved in the formation of intermolecular and intramolecular disulfide bonds related with its therapeutic bioactivity. Our recent experimental results based upon the heterologous expression of these two proteins in E. coli suggest the technical importance associated with in vivo disulfide bond formation, which could be mediated in a more effective, rigorous, specific, and controllable manner at the bioprocessing stage of either cultivation or downstream processing. To overcome these technical hurdles as the objective of the proposed research, the host and vector system will be genetically manipulated to enhance the expression level, folding efficiency, disulfide bond formation, stability, and bioactivity of the recombinant proteins. The scientific and technical development primarily includes: (1) recombinant DNA technology for gene overexpression, (2) fusion protein and chaperone coexpression technologies to increase the protein solubility, (3) graft of a genetic system for effective formation of disulfide bonds and precise targeting of recombinant proteins in various expression compartments, (4) design of mutant derivatives for consistent and controllable disulfide bond formation, and (5) downstream bioprocessing associated with these molecular strategies for bioactivity development and protein recovery. The outcome of the proposed research is expected to not only shed light on enhancing the efficiency of various posttranslational processings upon heterologous gene overexpression in E. coli but also complement the technical deficiencies currently limiting the expression of eukaryotic proteins in the prokaryotic system of E. coli for many biomanufacturing applications.
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
283237-2009
Name nom
Chou, CPerry
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2009
Award amount
23000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1206
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Engineering
Area of application fr
Génie
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
5
Nb partie
5
Application title
Molecular and bioprocessing strategies in posttranslational processing to enhance recombinant protein production
Keyword
NSERC
Application summary
In this proposed research, various molecular and bioprocessing aspects associated with disulfide bond formation will be explored and integrated with the strategies for gene overexpression to improve the performance of heterologous expression. Two eukaryotic proteins, i.e. an industrial enzyme of PalB and a therapeutic protein of hCD83ext, will be used as the model molecules for study. PalB contains three intramolecular disulfide bonds which are critical for its solubility and enzymatic activity, whereas hCD83ext contains five cysteine residues involved in the formation of intermolecular and intramolecular disulfide bonds related with its therapeutic bioactivity. Our recent experimental results based upon the heterologous expression of these two proteins in E. coli suggest the technical importance associated with in vivo disulfide bond formation, which could be mediated in a more effective, rigorous, specific, and controllable manner at the bioprocessing stage of either cultivation or downstream processing. To overcome these technical hurdles as the objective of the proposed research, the host and vector system will be genetically manipulated to enhance the expression level, folding efficiency, disulfide bond formation, stability, and bioactivity of the recombinant proteins. The scientific and technical development primarily includes: (1) recombinant DNA technology for gene overexpression, (2) fusion protein and chaperone coexpression technologies to increase the protein solubility, (3) graft of a genetic system for effective formation of disulfide bonds and precise targeting of recombinant proteins in various expression compartments, (4) design of mutant derivatives for consistent and controllable disulfide bond formation, and (5) downstream bioprocessing associated with these molecular strategies for bioactivity development and protein recovery. The outcome of the proposed research is expected to not only shed light on enhancing the efficiency of various posttranslational processings upon heterologous gene overexpression in E. coli but also complement the technical deficiencies currently limiting the expression of eukaryotic proteins in the prokaryotic system of E. coli for many biomanufacturing applications.